Cargando…
The Effect of Intravitreal Bevacizumab in Patients with Acute Central Serous Chorioretinopathy
PURPOSE: To evaluate the effect of intravitreal bevacizumab injection (IVBI) in acute central serous chorioretinopathy (CSC) patients. METHODS: Patients with acute CSC received IVBI (1.25 mg/0.05 mL) or observation by randomization. Twelve eyes in each group completed 6 months of regular follow-up a...
Autores principales: | Lim, Ji Won, Ryu, Su Jeong, Shin, Min Cheol |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Ophthalmological Society
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882078/ https://www.ncbi.nlm.nih.gov/pubmed/20532141 http://dx.doi.org/10.3341/kjo.2010.24.3.155 |
Ejemplares similares
-
The Effect of Intravitreal Bevacizumab on Central Serous Chorioretinopathy
por: Maleki, Alireza, et al.
Publicado: (2018) -
Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy
por: Ünlü, Cihan, et al.
Publicado: (2016) -
Changes in the Choroidal Thickness following Intravitreal Bevacizumab Injection in Chronic Central Serous Chorioretinopathy
por: Chung, Yoo-Ri, et al.
Publicado: (2022) -
Intravitreal bevacizumab administration for the treatment of chronic central serous chorioretinopathy
por: Alishiri, Aliagha, et al.
Publicado: (2019) -
Long-term treatment response after intravitreal bevacizumab injections for patients with central serous chorioretinopathy
por: Kang, Hae Min, et al.
Publicado: (2020)